ARGX-118

ARGX-118 was designed as a highly differentiated antibody against Galectin-10, the protein of Charcot-Leyden crystals (CLCs), which are implicated as a major contributor to airway inflammation and to the persistence of mucus plugs.

Neurology
Hematology / Rheumatology
Dermatology
Nephrology
Indication not disclosed
Program
Clinical trial

Pipeline

Ziel
Galectin-10
Preclinical
Phase 1
Proof of Concept
Registrational
Commercial
Airway Inflammation

Potential in severe airway inflammation indications